ΠΠΈΡΡΡ ΠΠΏΡΡΠ΅ΠΉΠ½Π°-ΠΠ°ΡΡ ΠΈ ΡΠ°ΠΊ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°: ΠΠΎΠΈΡΠΊ ΠΈ Π°Π½Π°Π»ΠΈΠ· Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ²
Π Ρ ΠΎΠ΄Π΅ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π»ΠΎΡΡ ΡΠ΅ΡΠΈΡΡ ΡΠ»Π΅Π΄ΡΡΡΠΈΠ΅ Π·Π°Π΄Π°ΡΠΈ: ΡΠΎΠ·Π΄Π°ΡΡ Π°ΡΡ ΠΈΠ² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π° ΠΎΡ Π±ΠΎΠ»ΡΠ½ΡΡ Π Π (ΠΏΠ°ΡΠ°ΡΠΈΠ½ΠΎΠ²ΡΠ΅ Π±Π»ΠΎΠΊΠΈ Ρ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠ°ΠΌΠΈ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ, ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΠΉ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π», ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΊΡΠΎΠ²ΠΈ) — ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΡ ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΠΉ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΎΡ Π±ΠΎΠ»ΡΠ½ΡΡ Π Π ΠΈΠ· Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΈΡ ΡΠ΅Π³ΠΈΠΎΠ½ΠΎΠ² Π ΠΎΡΡΠΈΠΈ ΠΈ ΡΡΡΠ°Π½ Π±ΡΠ²ΡΠ΅Π³ΠΎ Π‘Π‘Π‘Π Π½Π° ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠ΅ Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΈ Π² ΡΠ΅Π°ΠΊΡΠΈΠΈ Π³ΠΈΠ±ΡΠΈΠ΄ΠΈΠ·Π°ΡΠΈΠΈ in situ (ISH) Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΠ΅ΡΠ΅ΡΠ΅Π½Ρ ΡΠΎΠΊΡΠ°ΡΠ΅Π½ΠΈΠΉ ΠΈ ΡΡΠ»ΠΎΠ²Π½ΡΡ ΠΎΠ±ΠΎΠ·Π½Π°ΡΠ΅Π½ΠΈΠΉ
- ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅
- 1. ΠΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- 1. 1. ΠΠ±ΡΠ°Ρ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° ΠΠΠ
- 1. 2. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ ΠΠΠ
- 1. 3. ΠΠΈΠ·Π½Π΅Π½Π½ΡΠΉ ΡΠΈΠΊΠ» Π²ΠΈΡΡΡΠ°
- 1. 3. 1. ΠΠΈΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ
- 1. 3. 2. ΠΠ°ΡΠ΅Π½ΡΠ½Π°Ρ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ
- 1. 3. 2. 1. EBERs
- 1. 3. 2. 2. Π―Π΄Π΅ΡΠ½ΡΠ΅ Π±Π΅Π»ΠΊΠΈ
- 1. 3. 2. 3. ΠΠ°ΡΠ΅Π½ΡΠ½ΡΠ΅ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΡΠ΅ Π±Π΅Π»ΠΊΠΈ
- 1. 4. ΠΠ°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°, ΡΠ²ΡΠ·Π°Π½Π½ΡΠ΅ Ρ ΠΠΠ
- 1. 4. 1. ΠΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΠΉ ΠΌΠΎΠ½ΠΎΠ½ΡΠΊΠ»Π΅ΠΎΠ·
- 1. 4. 2. ΠΠΈΠΌΡΠΎΠΌΠ° ΠΠ΅ΡΠΊΠΈΡΡΠ°
- 1. 4. 3. ΠΠΈΠΌΡΠΎΠ³ΡΠ°Π½ΡΠ»Π΅ΠΌΠ°ΡΠΎΠ·
- 1. 4. 4. ΠΠ΅Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ ΡΠ°ΠΊ Π½ΠΎΡΠΎΠ³Π»ΠΎΡΠΊΠΈ
- 1. 4. 5. Π Π°ΠΊ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°
- 3. 1. ΠΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΡΡΠ²ΠΎ ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΡ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠΎΡΠΌ Π Π Π² Π ΠΎΡΡΠΈΠΈ
- 3. 2. Π₯Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΡΠΎΡΠΌ Π Π Π² Π½Π΅ΠΊΠΎΡΠΎΡΡΡ
ΡΠ΅Π³ΠΈΠΎΠ½Π°Ρ
Π ΠΎΡΡΠΈΠΈ ΠΈ Π±ΡΠ²ΡΠ΅Π³ΠΎ Π‘Π‘Π‘Π
- 3. 2. 1. ΠΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΈΠ΅ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠ»ΡΡΠ°Π΅Π² Π Π ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π³ΠΈΠ±ΡΠΈΠ΄ΠΈΠ·Π°ΡΠΈΠΈ in situ
- 3. 2. 2. ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π³ΡΠΌΠΎΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° ΠΊ Π±Π΅Π»ΠΊΠ°ΠΌ ΠΠΠ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠΎΡΠΌΠΎΠΉ Π Π 65 3.3 ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² LMP1 ΠΠΠ, Π°ΠΌΠΏΠ»ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΈΠ· ΡΠΊΠ°Π½Π΅ΠΉ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°
- 3. 3. 1. ΠΠΎΠΈΡΠΊ ΠΈ ΠΎΡΠ±ΠΎΡ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠ»ΡΡΠ°Π΅Π² Π Π
- 3. 3. 2. ΠΠΌΠΏΠ»ΠΈΡΠΈΠΊΠ°ΡΠΈΡ, ΠΊΠ»ΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈ ΡΠΈΠΊΠ²Π΅Π½ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² LMP1, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ ΠΈΠ· ΡΠΊΠ°Π½Π΅ΠΉ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°
- 3. 3. 3. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ ΠΈ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ·
ΠΠΈΡΡΡ ΠΠΏΡΡΠ΅ΠΉΠ½Π°-ΠΠ°ΡΡ ΠΈ ΡΠ°ΠΊ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°: ΠΠΎΠΈΡΠΊ ΠΈ Π°Π½Π°Π»ΠΈΠ· Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΡΠΎΠ»ΠΈ Π²ΠΈΡΡΡΠΎΠ² Π² Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΠΈ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΡΠΎΡΡΠ°Π²Π»ΡΠ΅Ρ Π²Π°ΠΆΠ½ΡΠΉ Π°ΡΠΏΠ΅ΠΊΡ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Π² ΠΎΠ±Π»Π°ΡΡΠΈ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ. Π‘ΡΠ΅Π΄ΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ ΠΎΠ½ΠΊΠΎΠ³Π΅Π½Π½ΡΡ Π²ΠΈΡΡΡΠΎΠ² ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ΅Ρ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅Ρ Π²ΠΈΡΡΡ ΠΠΏΡΡΠ΅ΠΉΠ½Π°-ΠΠ°ΡΡ (ΠΠΠ), ΠΊΠΎΡΠΎΡΡΠΉ ΠΎΡΠ½ΠΎΡΠΈΡΡΡ ΠΊ ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²Ρ Π³Π΅ΡΠΏΠ΅ΡΠ²ΠΈΡΡΡΠΎΠ², ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ±ΠΈΠΊΠ²ΠΈΡΠ°ΡΠ½ΡΠΌ ΠΈ ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΠ΅Ρ Π² ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ΅ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π²ΡΠ΅ΠΉ ΠΆΠΈΠ·Π½ΠΈ. Π‘ ΡΡΠΈΠΌ Π²ΠΈΡΡΡΠΎΠΌ ΡΠ²ΡΠ·ΡΠ²Π°ΡΡ Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΠ΅ Π°ΡΡΠΈΠΊΠ°Π½ΡΠΊΠΎΠΉ Π»ΠΈΠΌΡΠΎΠΌΡ ΠΠ΅ΡΠΊΠΈΡΡΠ° (ΠΠ), Π½Π΅Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ° Π½ΠΎΡΠΎΠ³Π»ΠΎΡΠΊΠΈ (Π½Π ΠΠ), Π-ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ Π»ΠΈΠΌΡΠΎΠΌ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ ΠΈΠΌΠΌΡΠ½ΠΎΠ΄Π΅ΡΠΈΡΠΈΡΠ°ΠΌΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠΈΡΡ ΠΎΠΆΠ΄Π΅Π½ΠΈΡ ΠΈ Π΄Ρ. /14, 141, 96/. Π‘ΠΏΠ΅ΠΊΡΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² Ρ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°, Π² Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΠΈ ΠΊΠΎΡΠΎΡΡΡ , ΠΊΠ°ΠΊ ΠΏΠΎΠ»Π°Π³Π°ΡΡ, ΡΡΠ°ΡΡΠ²ΡΠ΅Ρ ΠΠΠ, ΠΏΠΎΡΡΠΎΡΠ½Π½ΠΎ ΡΠ°ΡΡΠΈΡΡΠ΅ΡΡΡ. Π Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΡΠΈΡΠΎΠΊΠΎ ΠΎΠ±ΡΡΠΆΠ΄Π°Π΅ΡΡΡ Π²ΠΎΠΏΡΠΎΡ ΠΎ ΡΠΎΠ»ΠΈ ΠΠΠ Π² ΠΏΡΠΎΡΠ΅ΡΡΠ΅ ΠΊΠ°Π½ΡΠ΅ΡΠΎΠ³Π΅Π½Π΅Π·Π° ΡΠΏΠΈΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°. ΠΡΡΠΌΡΠ΅ Π΄ΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΡΡΠ²Π° Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ ΠΠΠ ΠΈ ΡΠ°ΠΊΠ° ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° (Π Π) ΠΏΠΎΠ»ΡΡΠ΅Π½Ρ Π² ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΈΡ Π² ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ ΠΊΠ»Π΅ΡΠΊΠ°Ρ ΡΡΠ΄Π° Π²ΠΈΡΡΡΠ½ΡΡ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΡΠ°ΠΊΠΈΡ , Π½Π°ΠΏΡΠΈΠΌΠ΅Ρ, ΠΊΠ°ΠΊ Π ΠΠ Π³Π΅Π½Π° EBER1, Π±Π΅Π»ΠΊΠΎΠ² EBNA1 ΠΈ LMP2. ΠΡΠΎΠΌΠ΅ ΡΠΎΠ³ΠΎ, ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΠ΅ ΠΊΠ»Π΅ΡΠΊΠΈ, Π½Π΅ΡΡΡΠΈΠ΅ Π³Π΅Π½ΠΎΠΌ Π²ΠΈΡΡΡΠ° ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½Ρ. ΠΠΈΡΡΡΠ½ΡΠ΅ ΠΌΠ°ΡΠΊΠ΅ΡΡ Π½Π°Ρ ΠΎΠ΄ΠΈΠ»ΠΈ Π² ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ ΠΊΠ»Π΅ΡΠΊΠ°Ρ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° Π»ΡΠ±ΠΎΠΉ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΡΠΊΡΡΡΡ, Π½ΠΎ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ ΠΏΡΠΈ Π½ΠΈΠ·ΠΊΠΎΠ΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠΎΡΠΌΠ°Ρ Ρ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΠΉ Π»ΠΈΠΌΡΠΎΠΈΠ΄Π½ΠΎΠΉ ΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠ΅ΠΉ /130/.
Π£ΡΠΈΡΡΠ²Π°Ρ ΡΠΎΡ ΡΠ°ΠΊΡ, ΡΡΠΎ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈ 95−100% Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ ΠΏΠ»Π°Π½Π΅ΡΡ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΎ ΠΠΠ, ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΡ Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ Ρ ΡΡΠΈΠΌ Π²ΠΈΡΡΡΠΎΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, Π²ΠΊΠ»ΡΡΠ°Ρ ΠΈ Π Π, ΠΎΡΡΠ°Π΅ΡΡΡ ΠΎΡΠΊΡΡΡΡΠΌ. ΠΠΎΠ·Π½ΠΈΠΊΠ°Π΅Ρ Π²ΠΎΠΏΡΠΎΡ, ΠΎΠ΄ΠΈΠ½ ΠΈ ΡΠΎΡ ΠΆΠ΅ ΠΈΠ»ΠΈ ΡΠ°Π·Π½ΡΠ΅ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π²Π°ΡΠΈΠ°Π½ΡΡ Π²ΠΈΡΡΡΠ° ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΡΡ Ρ Π·Π΄ΠΎΡΠΎΠ²ΡΡ ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ Π»ΠΈΡ, Π² ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ ΠΈ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈ «Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΡ » ΠΊΠ»Π΅ΡΠΊΠ°Ρ . Π ΡΡΠΎΠΉ ΡΠ²ΡΠ·ΠΈ, Π³Π΅Π½ ΠΠΠ — BNRF1, ΠΊΠΎΠ΄ΠΈΡΡΡΡΠΈΠΉ Π»Π°ΡΠ΅Π½ΡΠ½ΡΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΡΠΉ Π±Π΅Π»ΠΎΠΊ 1 (LMP1) ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅Ρ ΠΎΡΠΎΠ±ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ΅Ρ. ΠΠΎ-ΠΏΠ΅ΡΠ²ΡΡ , ΡΡΠΎ ΠΎΠ΄ΠΈΠ½ ΠΈΠ· 6 Π½Π΅ΠΌΠ½ΠΎΠ³ΠΈΡ Π³Π΅Π½ΠΎΠ² ΠΠΠ, ΠΊΠΎΡΠΎΡΡΠΉ ΠΎΠ±Π»Π°Π΄Π°Π΅Ρ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠΈΡΡΡΡΠΈΠΌ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΠΎΠΌΠ²ΠΎ-Π²ΡΠΎΡΡΡ , ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΡΠ΅ ΡΡΡΡΠΊΡΡΡΠ½ΡΠ΅ ΠΏΠ΅ΡΠ΅ΡΡΡΠΎΠΉΠΊΠΈ ΡΡΠΎΠ³ΠΎ Π³Π΅Π½Π° ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΡΡ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠΈΡΡΡΡΠ΅Π³ΠΎ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»Π° Π²ΠΈΡΡΡΠ° /53/. ΠΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ, Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠΈΠΉ Π³Π»ΡΠ±ΠΎΠΊΠΈΠΉ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· «ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ » ΠΈ «Π½Π΅ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ » Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² ΠΠΠ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ, ΠΏΠΎ ΠΊΡΠ°ΠΉΠ½Π΅ΠΉ ΠΌΠ΅ΡΠ΅, ΠΏΡΠΈΠ±Π»ΠΈΠ·ΠΈΡΡΡΡ ΠΊ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΏΠΎΡΡΠ°Π²Π»Π΅Π½Π½ΠΎΠ³ΠΎ Π²ΠΎΠΏΡΠΎΡΠ°.
Π Π°ΠΊ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° Π² Π ΠΎΡΡΠΈΠΈ Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ ΠΎΠ΄Π½ΠΎ ΠΈΠ· Π²Π΅Π΄ΡΡΠΈΡ ΠΌΠ΅ΡΡ ΡΡΠ΅Π΄ΠΈ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ Π²ΡΡΡΠ΅ΡΠ°ΡΡΠΈΡ ΡΡ Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠΉ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° /3/. Π ΡΠ²ΡΠ·ΠΈ Ρ ΡΡΠΈΠΌ, ΠΏΠΎΠΈΡΠΊ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠ»ΡΡΠ°Π΅Π² Π Π (ΠΠΠ+Π Π), ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΈΡ ΡΠ°ΡΡΠΎΡΡ ΡΡΠ΅Π΄ΠΈ Π²ΡΠ΅Ρ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ ΡΡΠΎΠΉ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ Π²ΡΡΡΠ½Π΅Π½ΠΈΠ΅ ΡΠΎΠ»ΠΈ Π²ΠΈΡΡΡΠ° Π² ΠΈΡ ΡΡΠΈΠΎΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅, ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅ΡΡΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΠΉ Π½Π°ΡΡΠ½ΠΎΠΉ ΠΈ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π·Π°Π΄Π°ΡΠ΅ΠΉ.
Π¦Π΅Π»ΡΡ Π½Π°ΡΡΠΎΡΡΠ΅ΠΉ Π΄ΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΡ ΡΠ²ΠΈΠ»ΠΎΡΡ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΈΠ΅ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠΎΡΠΌ ΡΠ°ΠΊΠ° ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° Π² Π½Π΅ΠΊΠΎΡΠΎΡΡΡ ΡΠ΅Π³ΠΈΠΎΠ½Π°Ρ Π ΠΎΡΡΠΈΠΈ Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌ ΡΡΠΎΠ²Π½Π΅ΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ Π Π, ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΈΡ ΡΠ΄Π΅Π»ΡΠ½ΠΎΠ³ΠΎ Π²Π΅ΡΠ° ΡΡΠ΅Π΄ΠΈ Π½ΠΎΠ²ΠΎΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠΉ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°, ΡΠ΅ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ°, Π° ΡΠ°ΠΊΠΆΠ΅ Π΄Π΅ΡΠ°Π»ΡΠ½ΠΎΠ΅ Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅, ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅.
Π Ρ ΠΎΠ΄Π΅ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π»ΠΎΡΡ ΡΠ΅ΡΠΈΡΡ ΡΠ»Π΅Π΄ΡΡΡΠΈΠ΅ Π·Π°Π΄Π°ΡΠΈ: ΡΠΎΠ·Π΄Π°ΡΡ Π°ΡΡ ΠΈΠ² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π° ΠΎΡ Π±ΠΎΠ»ΡΠ½ΡΡ Π Π (ΠΏΠ°ΡΠ°ΡΠΈΠ½ΠΎΠ²ΡΠ΅ Π±Π»ΠΎΠΊΠΈ Ρ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠ°ΠΌΠΈ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ, ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΠΉ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π», ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΊΡΠΎΠ²ΠΈ) — ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΡ ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΠΉ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΎΡ Π±ΠΎΠ»ΡΠ½ΡΡ Π Π ΠΈΠ· Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΈΡ ΡΠ΅Π³ΠΈΠΎΠ½ΠΎΠ² Π ΠΎΡΡΠΈΠΈ ΠΈ ΡΡΡΠ°Π½ Π±ΡΠ²ΡΠ΅Π³ΠΎ Π‘Π‘Π‘Π Π½Π° ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠ΅ Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΈ Π² ΡΠ΅Π°ΠΊΡΠΈΠΈ Π³ΠΈΠ±ΡΠΈΠ΄ΠΈΠ·Π°ΡΠΈΠΈ in situ (ISH) Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ Π²ΠΈΡΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΠΊΠ΅ΡΠ° Π ΠΠ Π³Π΅Π½Π° EBER1 ΠΠΠΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°ΡΡ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΡΡ ΡΡΡΡΠΊΡΡΡΡ ΡΠ»ΡΡΠ°Π΅Π² Π Π, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ Ρ ΠΠΠΠΏΡΠΎΠ²Π΅ΡΡΠΈ ΡΠΊΡΠΈΠ½ΠΈΠ½Π³ ΡΡΠ²ΠΎΡΠΎΡΠΎΠΊ Π±ΠΎΠ»ΡΠ½ΡΡ Π Π ΠΈ Π·Π΄ΠΎΡΠΎΠ²ΡΡ Π½ΠΎΡΠΈΡΠ΅Π»Π΅ΠΉ Π½Π° Π½Π°Π»ΠΈΡΠΈΠ΅ ΠΈ ΡΠΈΡΡΡ Π°Π½ΡΠΈΡΠ΅Π» ΠΊ Π±Π΅Π»ΠΊΠ°ΠΌ Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠΊΠ»Π° ΠΠΠ- 7 ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΡΡ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΡΡ Π½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄Π½ΡΡ ΡΡΡΡΠΊΡΡΡΡ ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΈΠ· Π³Π΅Π½ΠΎΠ² Π»Π°ΡΠ΅Π½ΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΠΠ — LMP1, Π°ΠΌΠΏΠ»ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΈΠ· ΠΎΠ±ΡΠ°Π·ΡΠΎΠ² ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΠΎΠΉ ΠΈ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈ Π½Π΅ΠΈΠ·ΠΌΠ΅Π½Π΅Π½Π½ΠΎΠΉ ΡΠΊΠ°Π½Π΅ΠΉ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°, Π±ΠΎΠ»ΡΠ½ΡΡ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠΎΡΠΌΠΎΠΉ Π ΠΡΡΠ±ΠΊΠ»ΠΎΠ½ΠΈΡΠΎΠ²Π°ΡΡ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π²Π°ΡΠΈΠ°Π½ΡΡ LMP1 ΠΠΠ Π² ΡΡΠΊΠ°ΡΠΈΠΎΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΡΡΡΠΈΠΉ Π²Π΅ΠΊΡΠΎΡ ΠΈ ΠΈΠ·ΡΡΠΈΡΡ ΠΈΡ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ΅ ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅.
ΠΠ°ΡΡΠ½Π°Ρ Π½ΠΎΠ²ΠΈΠ·Π½Π° ΡΠ°Π±ΠΎΡΡ Π·Π°ΠΊΠ»ΡΡΠ°Π΅ΡΡΡ Π² ΡΠΎΠΌ, ΡΡΠΎ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ Π±ΡΠ» ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ ΠΏΠΎΠΈΡΠΊ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠ»ΡΡΠ°Π΅Π² Π Π Π² Π ΠΎΡΡΠΈΠΈ, ΠΎΡ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π½Π° ΠΈΡ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡΡΡΠΊΡΡΡΠ°, ΠΈΠ·ΡΡΠ΅Π½ Π³ΡΠΌΠΎΡΠ°Π»ΡΠ½ΡΠΉ ΠΎΡΠ²Π΅Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Π Π ΠΊ Π±Π΅Π»ΠΊΠ°ΠΌ Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠΊΠ»Π° ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΠΠ. ΠΡΠΎΠΌΠ΅ ΡΠΎΠ³ΠΎ, Π²ΠΏΠ΅ΡΠ²ΡΠ΅ Π±ΡΠ»ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ Π½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄Π½ΡΠ΅ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² ΠΏΠΎΠ»Π½ΠΎΡΠ°Π·ΠΌΠ΅ΡΠ½ΠΎΠ³ΠΎ Π³Π΅Π½Π° LMP1 ΠΠΠ, Π°ΠΌΠΏΠ»ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΈΠ· ΡΠΊΠ°Π½Π΅ΠΉ ΠΠΠ+Π ΠΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· ΠΏΠΎ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΠΈΡ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ ΠΈ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΠΈ Π°ΠΊΡΠΈΠ²ΠΈΡΠΎΠ²Π°ΡΡ ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΈΠΎΠ½Π½ΡΠΉ ΡΠ°ΠΊΡΠΎΡ NFkB.
ΠΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΡΠΎΡΡΠΎΠΈΡ Π² Π²ΡΡΠ²Π»Π΅Π½ΠΈΠΈ ΡΠΎΡΠΌ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ Ρ ΠΠΠ Π½Π° ΡΠ΅ΡΡΠΈΡΠΎΡΠΈΠΈ Π½Π°ΡΠ΅ΠΉ ΡΡΡΠ°Π½Ρ. ΠΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΈΠ΅ ΡΠ°ΠΊΠΈΡ ΡΠ»ΡΡΠ°Π΅Π² Π Π ΠΌΠΎΠΆΠ΅Ρ ΠΏΠΎΡΠ»ΡΠΆΠΈΡΡ Π²Π°ΠΆΠ½ΠΎΠΉ ΠΏΡΠ΅Π΄ΠΏΠΎΡΡΠ»ΠΊΠΎΠΉ Π΄Π»Ρ ΡΠ³Π»ΡΠ±Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΠΈΡ ΡΡΠΈΠΎΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π°, ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ Π½ΠΎΠ²ΡΡ ΠΏΠΎΠ΄Ρ ΠΎΠ΄ΠΎΠ² ΡΠ°Π½Π½Π΅ΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ, Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ, ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠΠ+Π Π. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ Π΄Π°Π½Π½ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Π±ΡΠ΄ΡΡ ΡΠ°ΠΊΠΆΠ΅ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΠΎΠ²Π°ΡΡ Π±ΠΎΠ»Π΅Π΅ Π³Π»ΡΠ±ΠΎΠΊΠΎΠΌΡ ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΡ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΊΠ°Π½ΡΠ΅ΡΠΎΠ³Π΅Π½Π΅Π·Π° Π½Π° ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· ΡΠΏΠΈΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΡΡ ΠΎΠΏΡΡ ΠΎΠ»Π΅ΠΉ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°. 8.
1. ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«.
ΠΠ«ΠΠΠΠ«.
1. ΠΠΏΠ΅ΡΠ²ΡΠ΅ ΡΠΎΠ³Π»Π°ΡΠ½ΠΎ Π΄Π°Π½Π½ΡΠΌ Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ, ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΠΌ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ Π½Π°Π»ΠΈΡΠΈΠ΅ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠΎΡΠΌ Π Π (ΠΠΠ+Π Π) Π² Π ΠΎΡΡΠΈΠΈ ΠΈ Π£Π·Π±Π΅ΠΊΠΈΡΡΠ°Π½Π΅. Π‘ΠΎΠ³Π»Π°ΡΠ½ΠΎ ΡΠ΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΠΌ (614 ΡΠ»ΡΡΠ°Π΅Π²) ΡΠ°ΡΡΠΎΡΠ° ΠΠΠ+Π Π ΡΠΎΡΡΠ°Π²Π»ΡΠ΅Ρ 7,3−15,7%.
2. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΡΠ»ΡΡΠ°ΠΈ Π Π: ΡΠ°ΡΠ΅ Π²ΡΡΡΠ΅ΡΠ°ΡΡΡΡ ΡΡΠ΅Π΄ΠΈ ΠΌΡΠΆΡΠΈΠ½ (16,8%), ΡΠ΅ΠΌ ΡΡΠ΅Π΄ΠΈ ΠΆΠ΅Π½ΡΠΈΠ½ (4,5%) — Π² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΌ ΠΏΡΠΈΠ½Π°Π΄Π»Π΅ΠΆΠ°Ρ ΠΊ Π½ΠΈΠ·ΠΊΠΎΠ΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ Π°Π΄Π΅Π½ΠΎΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠ΅ Ρ ΡΠΎΠ»ΠΈΠ΄Π½ΡΠΌ ΡΠΎΡΡΠΎΠΌ (18,0%) ΠΈ ΡΠΌΠ΅ΡΠ΅Π½Π½ΠΎΠ΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΡΠ±ΡΠ»ΡΡΠ½ΠΎΠΉ Π°Π΄Π΅Π½ΠΎΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠ΅ (15,3%) — ΡΠ΅Π΄ΠΊΠΎ Π»ΠΎΠΊΠ°Π»ΠΈΠ·ΡΡΡΡΡ Π² Π°Π½ΡΡΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ°ΡΡΠΈ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° (5,5%) — 80−100% ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠΎΠ΄Π΅ΡΠΆΠ°Ρ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΡΡ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡ ΠΠΠ, Π² ΡΠΎ Π²ΡΠ΅ΠΌΡ ΠΊΠ°ΠΊ ΠΈΠ½ΡΠΈΠ»ΡΡΡΠΈΡΡΡΡΠΈΠ΅ ΠΎΠΏΡΡ ΠΎΠ»Ρ Π»ΠΈΠΌΡΠΎΡΠΈΡΡ Π²ΠΈΡΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π° Π½Π΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Ρ.
3. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π²ΡΡΠΎΠΊΠ°Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π³ΡΠΌΠΎΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½Π½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° ΠΊ Π±Π΅Π»ΠΊΠ°ΠΌ ΠΠΠ Π² 70% ΡΠ»ΡΡΠ°Π΅Π² ΠΊΠΎΡΡΠ΅Π»ΠΈΡΡΠ΅Ρ Ρ ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠ΅ΠΌ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΈ ΠΠΠ Π² ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ ΠΊΠ»Π΅ΡΠΊΠ°Ρ ΡΡΠΈΡ ΠΆΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ Π Π.
4. ΠΠΏΠ΅ΡΠ²ΡΠ΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄Π½ΡΡ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠ΅ΠΉ Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² Π³Π΅Π½Π° LMP1 ΠΠΠ, Π°ΠΌΠΏΠ»ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΈΠ· ΡΠΊΠ°Π½Π΅ΠΉ ΠΠΠ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠ»ΡΡΠ°Π΅Π² Π Π. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ Π²Π°ΡΠΈΠ°Π½ΡΡ LMP1 ΠΠΠ+Π Π Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΡΡ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌ Π½Π°Π±ΠΎΡΠΎΠΌ ΡΠΎΡΠ΅ΡΠ½ΡΡ ΠΌΡΡΠ°ΡΠΈΠΉ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΠΎΡΠ»ΠΈΡΠ°ΡΡΠΈΡ ΠΈΡ ΠΎΡ ΡΠ°Π½Π΅Π΅ ΠΎΡ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π½Π½ΡΡ LMP1 Π‘Π°ΠΎ ΠΈ Π95.8, Π° ΡΠ°ΠΊ ΠΆΠ΅ LMP1, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ ΠΎΡ Π±ΠΎΠ»ΡΠ½ΡΡ Π½Π ΠΠ ΠΈ Π·Π΄ΠΎΡΠΎΠ²ΡΡ Π²ΠΈΡΡΡΠΎΠ½ΠΎΡΠΈΡΠ΅Π»Π΅ΠΉ ΠΈΠ· Π ΠΎΡΡΠΈΠΈ.
5. Π€ΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΊΠ»ΠΎΠ½ΠΎΠ² LMP1 ΠΠΠ+Π Π Π²ΠΏΠ΅ΡΠ²ΡΠ΅ ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ» ΡΠ°Π½Π΅Π΅ Π½Π΅ΠΈΠ·Π²Π΅ΡΡΠ½ΠΎΠ΅ ΡΠ²Π»Π΅Π½ΠΈΠ΅ ΠΈΠ½Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ Π³Π΅Π½Π° LMP1 ΠΠΠ.
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ²ΠΎΠΉΡΠΈΠ½ Π.Π., ΠΠΊΡΠ΅Π»Ρ Π. Π. Π’ΡΠ°ΠΏΠ΅Π·Π½ΠΈΠΊΠΎΠ² Π.Π. Π‘ΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ ΡΡΡΠ°Π½ Π‘ΠΠ Π² 1995 Π³.-Π.:ΠΠΠ¦ Π ΠΠΠ.-1996.-273Ρ.
- ΠΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΡΠ°ΠΊΠ° Π½ΠΎΡΠΎΠ³Π»ΠΎΡΠΊΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ΅ΡΠ΅Π»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Π²ΠΈΡΡΡΠ° ΠΠΏΡΡΠ°ΠΉΠ½Π°-ΠΠ°ΡΡ: Π£ΡΠ². Π£ΠΏΡ. ΠΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π³Π»Π°Π²Π½ΠΎΠ³ΠΎ Π£ΠΏΡ. ΠΠ΅Ρ.-ΠΏΡΠΎΡ. ΠΠΎΠΌΠΎΡΠΈ. Π., 1987.- 21Ρ.
- ΠΠ°Π½ΠΈΠ°ΡΠΈΡ Π’., Π€ΡΠΈΡ Π., Π‘ΡΠΌΠ±ΡΡΠΊ ΠΠΆ. ΠΠ΅ΡΠΎΠ΄Ρ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈΠ½ΠΆΠ΅Π½Π΅ΡΠΈΠΈ. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠ΅ ΠΊΠ»ΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅- ΠΠ΅Ρ. Ρ Π°Π½Π³Π».- Π.:ΠΠΈΡ, 1984.- 480 Ρ.
- Birnboim H.C., Doly J. A rapid alkaline axtraction procedure for screening: recombinant plasmid DNA //Nucleic Acids Res.-1979.-Vol.7.-1513.96
- Bochkarev A., Barwell J.A., Pfuetzner R.A., Bochkareva E., Frappier L., Edwards A.M. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin binding protein EBNA1, bound to DNA // Cell.-1996.-Vol. 84.-P. 791−800.
- Bonnet M., Guinebretiere J.M., Kremmer E., Grunewald V., Benhamou E., Contesso G., Joab I. Detection of Epstein-Barr virus in invasive breast cancers // J. Natl. Cancer Inst.-1999.-Vol.91.-P. 1376−1381.
- Boyer H.W., Roulland-Dussoix D. A complementation analysis of the restriction and modification of DNA in Escherichia coli // J. Mol. Biol.-1969.-Vol.4L-P.459−472.
- Burke A.P., Yen T.S.B., Shekitka K.M., Sobin L.H. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polemerase chain reaction // Mod. Pathol.-1990.-Vol.3.-P.377−380.
- Burkitt D.P. A carcinoma involving the jaws in African children // Br.J.Sur.-1958.-Vol.46.-P.218−223.
- Butler A.E., Colby T.V., Weiss L., Lombard C. Lymphoepithelioma-like carcinoma of the lung // Am. J. Serg. Pathol.-1989.-Vol.l3.-P.632−639.
- Ceccarelli D.F., Frappier L. Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus// J. Virol.-2000.-Vol.74.-P.4939−4948.97
- Clifford P. On the epidemiology of nasopharyngeal carcinoma // Int. J. Cancer. -I970.-Vol.5.-P.287−309.
- Cohen J.I., Wang F., Mannick J., Kieff E. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation // Proc. Acad. Natl. Sci. USA.-1989.-Vol. 86.-P.9558−9562.
- Cotter M.A. 2nd, Robertson E.S. Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha // Mol. Cell. Biol.-2000.-Vol.20.-P.5722−5735.
- Cruickshank J., Shire K., Davidson A.R., Edwards A.M., Frappier L. Two domains of the epstein-barr virus origin DNA-binding protein, EBNA1, orchestrate sequence-specific DNA binding // J. Biol. Chem.-2000.-Vol.275.-P.22 273−22 277.
- Dambaugh Π’., Raab-Traub N., Heller M., Beisel C., Hummel M., Cheung A., Fennewald S., King W., Kieff E. Variations among isolets of Epstain-Barr virus // Ann. N. Y. Acad. Sci.-1980.-354.-P.309−325.
- Dunn B.E., Vakil N.B., Schneider B.G., Miller M.M., Zitzer J.B., Peutz Π’., Phadnis S.H. Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies // Infect. Immun.-1997.-Vol.65.-P.-l 181−1188.
- Epstein M.A., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma // Lancet.-1964.-Vol.l.-P.252−253.
- Fahreus R., Rymo L., Rhim J.S., Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus // Nature.-1990.-Vol.345 .-P.447−449.
- Farrell P.J., Bankier A., Seguin C., Deininger P., Barrell B.G. Latent and lytic cycle promoters of Epstein-Barr virus // EMBO J.-1983.-Vol.2.-P.1331−1338.
- Fingeroth J.D., Clabby M.L., Strominger J.D. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21) // J.Virol.-1988.-Vol.62.-P.1442−1447.
- Fischer N., Kremmer E., Lautscham G., Mueller-Lantzsch N., Grasser F.A. Epstein-Barr virus nuclear antigene 1 forms a complex with the nuclear transporter karyopherin a2 //J.Biol.Chem.-1997.-Vol. 272.-P. 3999−4005.
- Fischer N., Kopper Π., Graf N., Schlehofer J.R., Grasser F.A., Mueller-Lantzsch N. Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers // Virus Res.-1999.-Vol.60.-P.41−54.
- Fries K.L., Miller W.E., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene // J. Virol.-1996.-Vol.70.-P.8653−8659.99
- Fukayama M., Hayashi Y., Iwasaki Y., Chong J., Ooba Π’., Takizawa Π’., Koike M., Mizutani S., Miyaki M., Hirai K. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach // Lab Invest.-1994.-Vol.71.-P.73−81.
- Gallo O., Di Lollo S., Grassani P., Gallina E., Baroni G. Detection of Epstein-Barr virus genome in sinonasal undifferentiated carcinoma by use of in situ hybridization // Otolaryngol. Head Neck Syrg.-1994.-Vol.l 12.-P.659−664.
- Gergely L., Klein G., Ernberg I. Host cell macromolecular synthesis in cell containing EBV-induced early antigens, studied by combined immunofluorescence and radioautography // Virology.-1971.-Vol.45.-P.22−29.
- Gires O., Kohlhuber F., Kilger E., Baumann M., Kieser A., Kieser C., Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins // EMBO J.-1999.-Vol.l8.-P.3064−3073.
- Gires O., Zimber-Strobl U., Gonnella R., Ueffmg M., Marschall G., Zeidler R., Pich D., Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule // EMBO J.-1997.-Vol. 16.-P.6131−6140.
- Gussander E., Adams A. Electron microscopic evidence for replication of circular Epstein-Barr virus genomes in latently infected Raji cells // J. Virol.-1984.-Vol.52.-P.549−556.100
- Hammerscmidt W., Sugden Π., Baichwal V.R. The trnsforming domain alone of the latent membrane protein of the Epstain-Barr virus is toxic to cells when expressed at the high levels // J. Virol.-1989.-Vol.63.-P.2469−2475.
- Harn H.J., Chang J.Y., Wang M.W., Ho L. I, Lee H.S., Chiang J.H., Lee W.H. Epstain-Barr virus-associated gastric adenocarcinoma in Taiwan // Hum Pathol.-1995.-Vol.26.-P.267−271.
- Henle G. Henle W., Diehl V. Relation of Burkitt’s tumour-associsted herpes-type virus infectious mononucleosis /7 Proc. Natl. Acad. Sci USA.- 1968.-Vol.59.-P.94−101.
- Henle G., Henle W. Immunofluorescence in cells derived from Burkitt’s lymphoma // J. Bacteriol.-1966.-Vol.91 .-P. 1248−1256.
- Howe J.G., Shu M.-D. Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and II promoter elements // Cell.-1989.-Vol.57.-P.825−834.
- Howe J.G., SteitzJ.A. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization // Proc. Natl. Acad. Sci. USA.-1986.-Vol.83.-P.9006−9010.
- Hsieh J.J., Zhou S., Chen L., Young D.B., Hayward S.D. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex // Proc. Natl. Acad. Sci. USA.-1999.-Vol.96.-P.23−28.101
- Hu L.F., Zabarovsky E.R., Chen F., Cao S.L., Ernberg I., Klein G. Winberg G. Isolation and sequencing of the Epstein-Bar virus BNLF-1 gene (LMP1) from a Chinese nasopharingeal carcinoma // J. Gen. Virol.-1991.-Vol.72.-P.2399−2409.
- Kaiser C., Laux G., Eick D., Jochner N., Bornkamm G.W., Kempkes B. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2 //J. Virol.-1999.-Vol.73.-P.4481−4484.
- Kieff E. Epstain-Barr virus and its replication //Fields B.N., Knipe D.M., Howley P., Chanock R.M., Melnick J.L., Month T.P., Roizman Π., Straus S.E., eds. Fields Virology, Philadelphia, Lippincott-Raven.-1996.-P.2343−2396.
- Kieser A., Kilger E., Gires O., Ueffmg M., Kolch W., Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activitu via the c-Jun N-terminal kinase cascade //EMBO J.-1997.-Vol.l6.-P.6478−6485.102
- Kitay M.K., Rowe D.T. Protein-protein interaction between Epstain-Barr virus nuclear antigene-LP and cellular gene products: binding of 70-kilodalton heat shock proteins // Virology.-1996.-Vol. 220.- P.91−99.
- Kleines M., Finke K., Ritter K., Schaade L. Induction of rgowth rate and transcriptional modulation of growth promoters and growth inhibitors in epithelial cells by EBV-LMP1 // Virus Res.-2000.-Vol.68.-P.63−69.
- Komano J., Maruo S., Kurozumi K., Oda Π’., Takada K. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt’s lymphoma cell line Akata // J. Virol.-1999.-Vol.73 .-P.9827−9831.
- Kushner S.R. An improved method for transformation of Escherichia coli with ColEl-derived plasmids. In: Genetic engineering (Boyer H.B. and Nicosia S., eds.).-Elsevier/North-Holland, Amsterdam.-1978.-P.17.
- Lee E.S., Locker J., Nalesnik M., Reyes J., Jaffe R., Alashari M., Nour Π., Tzakis A., Dickman P. S. The assiciation of the Epstein-barr virus with smooth-muscle tumors occurring after organ transplantation // New Engl. J. Med.-1995.-Vol.332.-P.19−25.
- Leoncini L., Vindigni C., Megha Π’., Funto I., Pacenti L., Musaro M., Renieri A., Seri M., Anagnostopoulos J., Tosi P. Epstein-Barr virus and gastric cancer: data adn unanswered questions // Int. J. Cancer.-1993.^-Vol.53.-P.898−901.103
- Leung S.Y., Chau K.Y., Yuen S.T., Chu K.M., Branicki F.J., Chung L.P. p53 overexpression is different in Epstain-Barr virus-associated and Epstain-Barr virus-negative carcinoma // Histopathology.-1998.-Vol.33.-P.311−317.
- Levine P.H., Stemmermann G., Lennette E.T., Hildesheim A., Shibata D., Nomura A. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma // Int. J. Cancer.-1995.-Vol.60.-P.642−644.
- Lieberman P.M., Berk A.J. In vitro transcriptional activation, dimerization, and DNA-binding spesifity of the Epstein-Barr virus Zta protein // J. Virol.-1990.-Vol.64.-P.2560−2568.
- Liebowitz D., Wang D., Kieff E. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus // J. Virol.-1986.-Vol.58.-P 233 237.
- Liebowitz D., Mannick J., Takada K., Kieff E. Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains nesessary for effects in B-lymphoma cells // J. Virol.-1992.-Vol.6.-P.4612−4616.
- Lin C.S., Kuo H.H., Chen J.Y., Yang C.S., Wang W.B. Epstein-Barr virus nuclear antigen 2 retards cell growth induces p21(WAFl) expression and modulates p53 activity post-translationally // J. Mol. Biol.-2000.-Vol.303.-P.7−23.
- Longnecker R., Kieff E. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocolizes with LMP1 // J. Virol.-1990.-Vol.64.-P.2319−2326.
- Luka J., Kallin Π., Klein G. Induction of the Epstain-Barr virus (EBV) cycle in latently infected cells by n-butyrate // Virology.-1979.-Vol.94.-P.228−231.104
- Mackey D., Sugden Π. The linking regions of EBNA1 are essential for its support of replication and transcription // Mol. Cell. Biol.-1999.-Vol.l9.-P.3349−3359.
- Mann K.P., Staunton D., Thorley-Lawson D.A. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells // J.Virol.-1985.-Vol.55.-P.710−720.
- Mannic J.B., Cohen J.I., Birkenbach M., Marchini A., Kieff E. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation // J. Virol.-1991.-Vol.65.-P.6827−6837.
- Manolov G., Manolova Y. Marker band in one chromosome 14 from Burkitt lymphoma // Nature.-1972.-Vol.237.-P.33−34.
- Matsunou H., Konishi F., Hori H., Ikeda Π’., Sasaki K., Hirose Y., Yamamichi N. Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan // Cancer -1996.-Vol.77.-P.1998−2004.
- Matsuo Π’., Heller M., Petti L., O’Shiro E., Kieff E. Persistence of the active Epstain-Barr virus genome integrated into human lymphocyte DNA // Science.-1984.-226.-P. 1322−1325.
- Miller G. Epstein-Barr virus. Biology, pathogenesis and medical aspect. In B.N.Fields and D.M.Knipe (ed.). Virology Raven Press, New York.-1990.-P.l 921−1958.
- Miller C.N., Lee J.H., Kieff E., Longnecker R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking // Proc. Natl. Acad. Sci. USA.-1994.-Vol.91.-P.772−776.
- Miyasashita E.M., Yang Π., Lam K.M., Crawford D.H., Thorley-Lawson D.A. A novel form of Epstein-Barr virus latency in normal Π cells in vivo // Cell.-1995.-Vol.80.-P.593−601.
- Moorthy R.K., Thorley-Lawson D.A. Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1 // J. Virol.-1993.-Vol.67.-P.2637−2645.
- Old L.J., Clifford P., Boyse E.A., DeHavre E., Geering G., Oettgen H.F., Williamson B. Precipitating antibody in human sera to an antigen present in cultured Burkitt’s lymphoma cells //Proc. Natl. Acad. Sci. USA.-1966.-Vol.56.-P. 1699−1704.
- Parker G.A., Touitou R., Allday M.J. Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis // Oncogene.-2000.-Vol.l9.-P.700−709.
- Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., Sibley R.K. Helicobacter pylori infection and the risk of gastric carcinoma // N. Engl. J. Med.-1991 .-Vol.325.-P. 1127−1131.106
- Petti L., Sample C., Kieff E. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins // Virology.-1990.-Vol. 176,-P.563−574.
- Purtilo D.T., Sakamoto K., Barnabei V. Epstein-Barr virus-induced diseases in boys with x-linked lymphoproliferative sindrome // Am. J. Med.-1982.-Vol.73.-P.49−56.
- Raab-Traub N., Dambaugh Π’., Kieff E. DNA of Epstain-Basrr virus VIII. B95−8, the previous prototype, is an unusual deletion derivative // Cell.-1980.-22.-P.257−267.
- Raab-Traub N., Flynn K. The structure of the termini of the Epstain-Barr virus as a marker of clonal cellular proliferation // Cell.-1986.-Vol.47.-P.883−889.
- Robinson J., Smith D., Niedermann J. Mitotic EBNA-positive lymphocytes in periferal blood during infectious mononucleosis // Nature.-1980.-Vol.287.-P.334−335.
- Rochford R, Miller C.L., Cannon M.J., Izumi K.M., Kieff E., Longnecker R. In vivo growth of Epstein-Barr virus transformed Π cells with mutations in latent membrane protein 2 (LMP2) // Arch. Virol.-1997.-Vol.l42.-P.707−720.107
- Rogers R.P., Speck S.H. Alternative splicing dicitates translasional starting Epstein-Barr virus transcripts // EMBO J.-1990.-Vol.9.-P.2273−2277.
- Rowe M., Rowe D.T., Gregory C.D., Young L.S., Farrell P.J., Rupani H., Rickinson A.B. Differences in Π cell phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt’s lymphoma cells // EMBO J.-1987.-Vol.6.-P.2743−2751.
- Saiki R.K., Gelfand D.H., Stoffel S., Scharf S. J, Higuchi R, Horn G.T., Mullis K.B., Ehrlich H.A. Primer-directed enzymatic amplification of DNA with thermostabile DNA polymerase // Scince.-1988.-Vol.239.-P.487−491.
- Saiki Y., Ohtani H., Naito Y., Miyazawa M., Nagura H. Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes // Lab. Invest.-1996.-Vol.75.-P.67−76.
- Sandvej K., Gratama J.W., Munch M., Zhou X.G., Bolhuis R.L., Andersen B.S., Gregersen N., Hamilton-Dutoit S. Sequence analysis of the Epstein-Barr virus108
- EBV) latent membrane protein-1 gene and promoter region: identification of 4 variants among wild-type EBV isolates // Blood.-1997.-Vol.90.-P 323−330.
- Sanger F., Nicklen S., Coulson A.R. DNA sequencing whith chain-terminating inhibitors // Proc. Natl. Acad. Sci. USA.-1977.-Vol.74.-P.5463−5467.
- Shibata D., Weiss L.M. Epstein-Barr virus-associated gastric adenocarcinoma // Am. J. Pathol.-1992.-Vol.l40.-P.769−774.
- Shousha S., Luqmani Y.A. Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa// J. Clin. Pathol.-1994.-Vol.47.-P.695−698.
- Shin W.S., Kang M.W., Kang J.H., Choi M.K., Ann B.M., Kim J. K., Sun H.S., Min K.W. Epstein-Barr virus-assiciated gastric adenocarcinomas among Koreans //Am. J. Clin. Pathol.-1996.-Vol. 105.-P.l 74−181.
- Sinclair A.J., Palmero I., Peters G., Farrell P.J. EBNA-2 and EBNA-LP cooperate to cause GO to G1 transition during immortalization of resting human Π lymphocytes by Epstein-Barr virus //EMBO J.-1994.-Vol.l4.-P.3321−3328.
- Sinha S.K., Todd S.C., Hedrick J.A., Speiser C.L., Lambris J.D., Tsoukas C.D. Characrization of the EBV/C3d receptor on the human Jurkat T cell line: Evidence for a novel transcript // J. Immunol.-1993.-Vol. 150.-P.5311−5320.
- Spruck III C. H, Tsai Y.C., Huang D.P., Yang A.S., Riedeot III W.M., Gonzalez-Zulueta M., Choi P., Lo K.W., Yu M.C., Jones PA. Absence of p53 gene mutations in primary nasopharyngeal carcinoma // Cancer Res.-1992.-Vol.52.-P.4787−4790.
- Summers H., Barwell J.A., Pfiietzner R.A., Edwards A.M., Frappier L. Cooperative assembly of EBNA1 on the EBV latent origin of replication // J. Virol.-1996.-Vol.70.-P. 1228−1231.
- Svadmyr E., Jondal M. Cytotoxic effector cells specific for B-cell lines transformed by Epstein-Barr virus are present with infectious mononucleosis // Proc. Natl. Acad. Sci.USA.-1975.-Vol.72.-P.1622−1626.
- Swaminathan S., Tomkinson Π., Kieff E. Recombinant Epstein-Barr virus with small RNA (EBER) gene deleted transforms lymphocytes and replicates in vitro // Proc. Natl. Acad. Sci. USA.-199L-Vol.88.-P. 1546−1550.
- Takada K. Epstein-Barr virus and gastric carcinoma // Cancer.-1999.-Vol.6.-P.95−100.
- Thorley-Lawson D.A., Geilinger K. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity // Proc. Natl Acad.Sci. USA.-l980.-Vol.77.-P.5307−5311.
- Toczyski D.P., Matera A.G., Ward D.C., Steitz J.A. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human Π lymphocytes // Proc. Natl. Acad. USA.-1994.-Vol.91.-P.3463−3467.
- Tong X., Wang F., Thut C., Kieff E. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40 and RPA70 but not with TBR // J.Virol.-1995.-Vol.69.-P.585−588.
- Tsai C.C., Chen C.L., Hsu H.C. Expression of Epstein-Barr virus in carcinomas of major salivary glands: a strong association with lymphoepithelioma-like carcinoma // Hum. Pathol.-1996.-Vol.27.-P.258−262.
- Van Grunsven W.M.J., Spaan J.M., Middeldorf J.M. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein // J. Infect. Dis.-1994.-Vol.l70.-P.13−19.
- Waltzer L., Perricaudet M., Sergeant A., Manet E. Epstein-Barr virus EBNA ΠΠ and EBNA 3C proteins both repress RBP-Jk-EBNA2-activated transcription by inhibiting the binding of RBP-Jk to DNA // J. Virol.-1996.-Vol.70.-P.5909−5915.
- Wang D., Liebovitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells // Cell.-1985.-Vol.43.-P.831−840.
- Wang F., Petti L., Braun D., Seung S., Kieff E. A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latenly infected, growth-transformed lymphocytes // J. Virol.-1987.-Vol.61.-P.945−954.
- Weiss L.M., Strickler J.G., Warnke R.A., Purtilo D.T., Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin’s desease // Am. J. Pathol.-1987.-Vol.l29.-P.86−91.
- Wilson J.B., Levine A.J. The oncogenic potential of EBV nuclear antigen 1 in transgenic mice // Curr. Top. Microbiol. Immunol.-1992.-Vol.l82.-P.375−384.
- Wolf H., zur Hausen H., Becker V. EB viral genomes in epithelial nasopharyngeal carcinoma cells // Nature.-1973.-Vol.244.-P.245−247.
- Yamamoto N., Tokunaga M., Uemura Y., Tanaka S., Shirahama H., Nakamura Π’., Land C.E., Sato E. Epstein-Barr virus and gastric remnant cancer // Cancer.-1994.-Vol.74.-P.805−809.
- Yamamoto N., Takizawa Π’., Iwanaga Y., Shimizu N., Yamamoto N. Malignant transformation of Π lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs // FEBS Letters.-2000.-Vol.24 249.-P.l-6.
- Yanai H., Takada K., Shimizu N., Mizugaki Y., Tada M., Okita K. Epstein-Barr virus infection in non-carcinomatous gastric epithelium // J. Pathol.-1997.-Vol.l83.-P.293−298.
- Yao Q.Y., Rowe M., Martin Π., Young L.S., Rickinson A.B. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers // J. Gen. Virol.-1991.-Vol.72.-P.1579−1590.
- Yoshiyama H., Shimizu N., Takada K., Persistent Epstein-Barr virus infection in a human T-cell line: Unique of latent virus expression // EMBO J.-1995.-Vol. 14.-P.3706−3711
- Zur Hausen H., Schulte-Holthausen H., Klein G., Henle W., Henle G., Clifford P., Santesson L. EBV DNA in biopsies of Burkitt tumours and anaplastic carsinomas of the nasopharynx // Nature.-1970.-Vol.228.-P.1056−1058.